CODX Capital Expenditures from 2010 to 2024

CODX Stock  USD 1.01  0.05  4.72%   
Co Diagnostics Capital Expenditures yearly trend continues to be fairly stable with very little volatility. Capital Expenditures is likely to outpace its year average in 2024. During the period from 2010 to 2024, Co Diagnostics Capital Expenditures regression line of annual values had r-squared of  0.71 and arithmetic mean of  409,618. View All Fundamentals
 
Capital Expenditures  
First Reported
2015-12-31
Previous Quarter
98.6 K
Current Value
174.4 K
Quarterly Volatility
159.6 K
 
Yuan Drop
 
Covid
Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 18 M, Selling General Administrative of 15 M or Total Revenue of 6.5 M, as well as many indicators such as Price To Sales Ratio of 5.44, Dividend Yield of 0.0 or PTB Ratio of 0.43. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Co Diagnostics Correlation against competitors.
For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.

Latest Co Diagnostics' Capital Expenditures Growth Pattern

Below is the plot of the Capital Expenditures of Co Diagnostics over the last few years. Capital Expenditures are funds used by Co Diagnostics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Co Diagnostics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is Co Diagnostics' Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Co Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Capital Expenditures10 Years Trend
Slightly volatile
   Capital Expenditures   
       Timeline  

CODX Capital Expenditures Regression Statistics

Arithmetic Mean409,618
Geometric Mean92,321
Coefficient Of Variation138.93
Mean Deviation482,954
Median113,246
Standard Deviation569,096
Sample Variance323.9B
Range1.4M
R-Value0.84
Mean Square Error100.1B
R-Squared0.71
Significance0.000075
Slope107,453
Total Sum of Squares4.5T

CODX Capital Expenditures History

20241.4 M
20231.4 M
20221.4 M
2021669.5 K
2020774.4 K
2019113.2 K
201841.3 K

About Co Diagnostics Financial Statements

Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' Capital Expenditures, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Expenditures1.4 M1.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.